Elkfork Partners’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$10.3M Buy
217,260
+95,438
+78% +$4.36M 0.25% 81
2019
Q2
$5.74M Buy
121,822
+32,164
+36% +$1.48M 0.14% 140
2019
Q1
$4.32M Sell
89,658
-14,824
-14% -$743K 0.11% 172
2018
Q4
$4.66M Sell
104,482
-21,488
-17% -$1.12M 0.13% 157
2018
Q3
$6.8M Sell
125,970
-1,122
-0.9% -$57.4K 0.16% 133
2018
Q2
$6.21M Sell
127,092
-7,242
-5% -$411K 0.16% 138
2018
Q1
$8.42M Buy
134,334
+39,508
+42% +$2.71M 0.23% 97
2017
Q4
$5.81M Buy
94,826
+43,452
+85% +$2.69M 0.16% 129
2017
Q3
$3.44M Sell
51,374
-7,718
-13% -$546K 0.1% 178
2017
Q2
$4.6M Sell
59,092
-42,194
-42% -$3.18M 0.14% 134
2017
Q1
$8.26M Sell
101,286
-16,694
-14% -$1.31M 0.25% 77
2016
Q4
$8.49M Buy
+117,980
New +$8.53M 0.28% 71

Other funds holding CAH

Elkfork Partners's CAH Position: Q3 2019 in Review

Elkfork Partners increased its Cardinal Health (CAH) stake by 78% in Q3 2019, buying an estimated $4.36M and bringing the position to 217,260 shares worth $10.3M. The position accounts for 0.25% of the portfolio, ranked #81.

Elkfork Partners first reported a position in CAH in Q4 2016 and has held it in 12 quarters since. 664 funds tracked by Wall St. Rank hold CAH as of Q3 2019.

  • Elkfork Partners held 217,260 shares of Cardinal Health worth $10.3M as of Q3 2019.
  • Elkfork Partners bought 95,438 Cardinal Health shares in Q3 2019, an estimated $4.36M.
  • Cardinal Health made up 0.25% of Elkfork Partners's portfolio in Q3 2019, its #81 holding.
  • Elkfork Partners first reported a position in Cardinal Health in Q4 2016 and has held it in 12 quarters since.
  • 664 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2019.

Based on Elkfork Partners's 13F filing for Q3 2019, filed 14 Nov 2019.